hero section gradient
15 handpicked stocks

Clear Skies for Airlines

This collection features companies ready to soar in the revitalized airline industry. Professional analysts have carefully selected these stocks to capture the travel sector's impressive recovery, from major carriers and aircraft manufacturers to online booking platforms.

Author avatar

Han Tan | Market Analyst

Published on July 11

Your Basket's Financial Footprint

Market capitalisation breakdown for the 'Clear Skies for Airlines' basket, highlighting large-cap dominance and investor takeaways.

Key Takeaways for Investors:
  • Large-cap dominance suggests generally lower volatility and performance that tends to track broader market moves.
  • Suitable as a core, long-term holding rather than a speculative, high-risk trade.
  • Expect steady long-term appreciation potential, not explosive short-term gains.
Total Market Cap
  • DAL: $40.69B

  • UAL: $32.41B

  • LUV: $18.21B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Delta's strong earnings and reinstated profit outlook signals a broader recovery throughout the travel ecosystem. This has created investment opportunities across the entire value chain, from airlines managing increased passenger volumes to manufacturers filling new orders and travel agencies handling more bookings.

2

What You Need to Know

This collection offers exposure to the entire air travel industry, making it a tactical opportunity to capitalize on sustained consumer and business travel spending. These stocks represent both direct players like airlines and the supporting companies that benefit from increased flight activity.

3

Why These Stocks

These companies were specifically selected to provide comprehensive exposure to the air travel recovery. The mix includes major carriers experiencing renewed demand, manufacturers supporting fleet expansions, and travel platforms handling increased booking traffic – all positioned to benefit from positive industry momentum.

Why You'll Want to Watch These Stocks

✈️

Cleared for Takeoff

Delta's strong earnings are typically a bellwether for the entire travel industry. When a major airline reports this level of success, it often signals wider opportunities across the entire sector.

💼

Business Travel Comeback

The return of lucrative business travel is boosting profit margins for airlines and travel platforms. This higher-margin segment is a key driver for many companies in this collection.

🔄

Full Industry Exposure

This collection gives you exposure to the entire air travel ecosystem, from the airlines themselves to the companies that build planes and the platforms where travelers book their trips.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions